__timestamp | Total Debt |
---|---|
Sunday, January 1, 1978 | 13925388 |
Saturday, January 1, 1983 | 6185500000 |
Sunday, January 1, 1984 | 8030900000 |
Tuesday, January 1, 1985 | 792770937840 |
Wednesday, January 1, 1986 | 940037595327 |
Thursday, January 1, 1987 | 1600657529925 |
Friday, January 1, 1988 | 1620171971443 |
Sunday, January 1, 1989 | 4463093227323.56 |
Monday, January 1, 1990 | 6370425218604.082 |
Tuesday, January 1, 1991 | 9474736298217.309 |
Wednesday, January 1, 1992 | 10667277027851.553 |
Friday, January 1, 1993 | 10591154242712.771 |
Saturday, January 1, 1994 | 9990956378722.215 |
Sunday, January 1, 1995 | 11579507782842.213 |
Monday, January 1, 1996 | 20632216518652.117 |
Wednesday, January 1, 1997 | 30037811665323.934 |
Thursday, January 1, 1998 | 55402071828518.664 |
Friday, January 1, 1999 | 57492326890969.914 |
Saturday, January 1, 2000 | 84353476466584.14 |
Monday, January 1, 2001 | 108436182484010.6 |
Tuesday, January 1, 2002 | 172999105148911.03 |
Wednesday, January 1, 2003 | 197334428944105.6 |
Thursday, January 1, 2004 | 183938680042120.3 |
Saturday, January 1, 2005 | 210219191296866.5 |
Sunday, January 1, 2006 | 261224869454704.72 |
Monday, January 1, 2007 | 298258367109668.5 |
Tuesday, January 1, 2008 | 340390906139935.1 |
Thursday, January 1, 2009 | 326172199818490.4 |
Friday, January 1, 2010 | 359715946168775.1 |
Saturday, January 1, 2011 | 347192190623809.8 |
Sunday, January 1, 2012 | 347459753665870 |
Tuesday, January 1, 2013 | 416970981818223.56 |
Wednesday, January 1, 2014 | 467429491575485.8 |
Thursday, January 1, 2015 | 554697837463125.8 |
Friday, January 1, 2016 | 539329407842494 |
Sunday, January 1, 2017 | 570048644476654 |
Monday, January 1, 2018 | 629990099574007 |
Tuesday, January 1, 2019 | 691933041492330.9 |
Wednesday, January 1, 2020 | 790585433275423.2 |
Friday, January 1, 2021 | 967480386076585.6 |
Saturday, January 1, 2022 | 972366628125877.1 |
Sunday, January 1, 2023 | 1152675551635034.8 |
Monday, January 1, 2024 | 176656638015773 |
Infusing magic into the data realm
The landscape of corporate debt in the United States has undergone significant transformations over the past few decades. From the modest debt levels of the late 1970s to the staggering figures of the 21st century, the trend is a testament to the evolving financial strategies of American companies.
In 1978, the total debt across all companies was a mere $13.9 million. Fast forward to 2000, and this figure had ballooned to approximately $83.9 billion, marking a dramatic increase of over 600,000%. The early 2000s saw a continued upward trajectory, with total debt reaching $172.4 billion by 2002, a near doubling in just two years.
The financial crisis of 2008 had a noticeable impact, with total debt peaking at $339.7 billion. However, the subsequent years showed resilience, with debt levels stabilizing around $358.9 billion by 2010.
The data reveals a consistent rise in corporate debt, reflecting broader economic trends and the increasing reliance on leverage for growth and expansion. By 2011, total debt stood at $346.5 billion, showcasing the enduring nature of corporate borrowing.
Understanding the historical trends of corporate debt provides valuable insights into the financial health and strategies of U.S. companies. As we move forward, monitoring these trends will be crucial for investors, policymakers, and business leaders alike.
5 Year Trend in Average Market Capitalization for AbbVie
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
Average Market Capitalization of Abbvie Annually
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Pharma Companies
5 Year Trend in Average Market Capitalization for AbbVie
5 Year Trend in Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Number of Employees for Top 10 Healthcare Companies
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters